Expression of novel kidney WT1 target genes is reduced in WT1 morphant kidney explants. Expression of Cxxc5 (A,A′), Lsp1 (C,C′), Pbx2 (E,E′), Rps6ka3 (I,I′), Scx (K,K′) and Sox11 (M,M′) in control morphant explants, demonstrating expression in nephron progenitor cells and other lineages. Plxdc2 (G,G′) is expressed predominantly in the outer region of the metanephric mesenchyme, a weak WT1-expression domain. In all cases, WT1 vivo-morpholino treatment results in a specific and marked reduction of target gene expression in nephron progenitor cells (B,B′,D,D′,F,F′,J,J′,L,L′,N,N′) or in mesenchyme peripheral to the nephron progenitors (H,H′). Dashed outlines demarcate the ureteric bud. Arrowheads denote regions shown in higher magnification in adjacent panels.